Detection and Quantification of Tp53 and p53-Anti-p53 Autoantibody Immune Complex: Promising Biomarkers in Early Stage Lung Cancer Diagnosis

Lung cancer is a leading cause of death worldwide, claiming nearly 1.80 million lives in 2020. Screening with low-dose computed tomography (LDCT) reduces lung cancer mortality by about 20% compared to standard chest X-rays among current or heavy smokers. However, several reports indicate that LDCT h...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Keum-Soo, Nimse, Satish Balasaheb, Warkad, Shrikant Dashrath, Kim, Jung-Hoon, Kim, Hey-Jin, Kim, Taisun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870326/
https://www.ncbi.nlm.nih.gov/pubmed/35200387
http://dx.doi.org/10.3390/bios12020127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870326/
https://www.ncbi.nlm.nih.gov/pubmed/35200387
http://dx.doi.org/10.3390/bios12020127

Ejemplares similares